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Vascular endothelial cells present luminal chemokines that arrest rolling leukocytes by activating integrins.
It appears that several chemokines must form higher-order oligomers to elicit proper in vivo effects, as
mutants restricted to forming dimers have lost the ability to recruit leukocytes to sites of inflammation.
Here, we show for the first time that the chemokine RANTES/CCL5 binds to the surface of human
endothelial cells in a regular filamentous pattern. Furthermore, the filaments bound to the surface in a
heparan sulfate-dependent manner. By electron microscopy we observed labeling for RANTES on
membrane projections as well as on the remaining plasma membrane. Mutant constructs of RANTES
restricted either in binding to heparin, or in forming dimers or tetramers, appeared either in a granular,
non-filamentous pattern or were not detectable on the cell surface. The RANTES filaments were also present
after exposure to flow, suggesting that they can be present in vivo. Taken together with the lacking in vivo or
in vitro effects of RANTES mutants, we suggest that the filamentous structures of RANTES may be of
physiological importance in leukocyte recruitment.
A
t sites of inflammation, activated endothelial cells present luminal adhesionmolecules and chemokines to
recruit circulating leukocytes. A crucial step in this process is the arrest of rolling leukocytes that is
triggered by chemokines and mediated by integrin activation1. Chemokines are a family of about 50
mainly secreted proteins which direct cellular migration through interaction with members of the seven trans-
membrane G protein coupled receptor family2–4. RANTES (regulated on activation, normal T cell expressed and
secreted)/CCL5 is a highly basic, 68 amino acid, inflammatory chemokine that recruits a wide variety of leuko-
cytes, includingmonocytes, granulocytes, T cells as well asmast cells and dendritic cells through interactions with
the chemokine receptors CCR1, CCR3, and CCR54.
Given that soluble chemokines would be rapidly washed away by the blood flow, chemokines are thought to be
immobilized at the luminal surface of endothelial cells through low affinity interactions with sulfated glycosa-
minoglycan chains (GAGs) of proteoglycans5–7. Support for this hypothesis comes from the inhibited binding of
chemokines to venules pretreated with heparinase8 as well as the reduced binding after targeted deletion of N-
acetyl glucosamine N-deacetylase–N-sulfotransferase-1 required for the addition of sulfate to the heparan sulfate
chains9. In vitro, several chemokines bind to GAGs such as heparin, heparan sulfate, chondroitin sulfate, and
dermatan sulfate5,10. To this end, mutagenesis studies on RANTES have shown that the interaction of RANTES
and heparin is mainly mediated through the highly basic BBXB motif 44RKNR47, located on the surface exposed
40s loop of the protein11,12. Replacement of these three basic residues with alanines (44AANA47) results in a variant
with a substantially reduced heparin affinity11,12 and a complete inability to recruit inflammatory cells to the
peritoneal cavity of mice13,14.
Another particular feature of RANTES is its propensity to oligomerize into higher-order complexes at high
concentrations, high pH or in the presence of GAG15,16. For quite sometime, it was unclear if such oligomerization
had any functional role or was merely an artifact of the high concentrations of protein used for structural studies.
However, when mutants designed to remain monomeric or dimeric were injected in the peritoneal cavity, they
failed to induce cellular recruitment, suggesting that in addition to GAG binding, oligomerization is required13,17.
Several experiments indicate that GAG binding and oligomerization of chemokines are also functionally
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coupled7,18. For example, RANTES and several other chemokines
may oligomerize on heparin beads. Dimeric forms of many chemo-
kines have also been reported to have higher affinity for GAGs than
their monomeric variants and GAG binding may involve, or induce,
oligomeric structures larger than dimers. For example, although
MCP-1/CCL2 forms a dimer in solution, a heparin octasaccharide
shifts the equilibrium toward MCP-1 tetramers19.
In the present study, we have analysed the distribution of endo-
genous and recombinant RANTES on vascular endothelial cells. We
show that secreted RANTES bound at the cell surface, not in a diffuse
or aggregated pattern, but surprisingly as specific, well ordered fila-
ments that elongated over time. The filamentous expression of
RANTES was not found when expressing mutants that are restricted
to form dimers or tetramers, or when expressing a mutant with
reduced GAG affinity. These data add further support to themerging
view that formation of higher order oligomers of RANTES is crucial
to elicit its fully biological function in activation of leukocytes.
Results
RANTES is organized in filament-like structures on the endothelial
cell surface. In a screen for chemokines that sort to the regulated
secretory pathway in endothelial cells, we observed by means of
immunofluorescent staining and confocal microscopy that RANTES
was expressed in patterns distinct from those of other chemokines20,21
(Øynebra˚ten et al., unpublished data). When HUVECs were cultured in
vitro and stimulated with TNFa in combination with IFNc before
fixation and immunostaining, RANTES mainly localized in elongated,
filamentous structures (Fig. 1A) and20. Five different antibodies towards
RANTES were tested, and they all labeled elongated structures of
RANTES. Analysis at different time points after exposing HUVECs
to TNFa and IFNc revealed that RANTES was distributed in puncta
and short elongated structures after 12 h. In the course of analysis these
structures elongated from an average length of 2 mm at 24 h to 15 mm
after 60 h of stimulation (Fig. 1A). Based on these observations, we
suggest that short structures of RANTES can develop into long
filaments in cultures of endothelial cells activated by pro-inflammatory
stimuli. To elucidate whether the filaments were present on the cell
surface, we stained live HUVECs kept on ice, observing that RANTES
filaments are subject to surface presentation on endothelial cells (Fig. 1B).
Several types of membrane projections have been described for
endothelial cells8,22–24, and indeed, RANTES as well as IL-8/CXCL8
have been detected on microvillous-like extensions on the luminal
endothelial cell surface8. We therefore asked whether RANTES fila-
ments are associated with membrane projections in HUVECs. To
this end, RANTES in cytokine-activated HUVECs was visualized by
anti-RANTES antibody, gold-labeling, and electron microscopy. In
these experiments, RANTES was observed both on HUVEC mem-
brane projections and the remaining plasma membrane (Fig. 1C,
1D). Although there was a tendency of more labeling on the mem-
brane projections, there was no significant difference in signal den-
sity between the two sites (Fig. S1).
Filament formation does not depend on TNFa1 IFNc-stimulation.
In agreement with a previous study25 we observed that RANTES was
most strongly induced in HUVECs by simultaneous stimulation with
TNFa and IFNc20. Because we did not observe filamentous organization
of chemokines in resting or IL-1b stimulated-HUVECs20,21 we asked if
Figure 1 | RANTES organizes in filaments on the cell surface and the filament length increases with incubation time in the presence of TNFa and IFNc.
(A)HUVECs were cultured in growthmediumwith 10 ng/ml TNFa and 1 ng/ml IFNc for different time points (indicated in each image) before fixation
and immunostaining with clone ID2/A12. Inserts show structure details at 33magnification. Scale bar, 10 mm. The images were acquired by widefield
microscopy. (B) HUVECs were stimulated with 10 ng/ml TNFa and 1 ng/ml IFNc for 30 h and then immunostained with a rabbit anti-RANTES
antibody on ice to label only extracellular, surface associated RANTES. Ulex, a lectin, was utilized to label the surface of all HUVECs. Scale bar, 10 mm.
Images were acquired by sequential scanning confocal microscopy. (C, D)HUVECs were stimulated with 10 ng/ml TNFa and 1 ng/ml IFNc for 36 h and
frozen for cryosectioning before immunogold detection of RANTES with a goat anti-RANTES antibody. The images show sections of the outer part of
HUVECs, with membrane projections originating from the cell surface (arrowheads). Arrows indicate immunogold labelled RANTES. pm, plasma
membrane; n, nucleus. Scale bars, 500 nm.
www.nature.com/scientificreports
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the particular expression pattern of RANTES might be associated with
the activation program induced by TNFa 1 IFNc-stimulation.
However, MCP-1/CCL2 showed a non-filamentous distribution/
pattern regardless of being labeled in HUVECs stimulated with IL-1b
or with TNFa 1 IFNc (Fig. 2A), indicating that TNFa 1 IFNc-
stimulation is generally not sufficient to induce a filamentous
organization of chemokines. On the other hand, when recombinant
RANTES was added to cultures of unstimulated HUVECs, RANTES
organized in filaments. The filaments were numerous following
incubation with 1 mg/ml of RANTES (Fig. 2B, left panel). In addition,
some patches of RANTES were observed, probably formed because of
the high RANTES concentration (Fig. 2B, left panel). Recombinant
RANTES in concentrations 1 and 10 ng/ml failed to induce filaments
(data not shown), suggesting that concentrations above 10 ng/ml are
necessary for filament formation when RANTES derive from an
extracellular source. Electroporation with a DNA plasmid encoding
RANTES, also resulted in filamentous organization of the protein
(Fig. 2B, right panel). Thus, filamentous organization is a property of
RANTES which does not depend on TNFa 1 IFNc-stimulation.
Extracellular molecules can polymerize RANTES.We next examined
whether RANTES alone can polymerize and form filaments or whether
other molecules are necessary (Fig. 3). First, we incubated RANTES
(1 mg/ml) with cell growth medium (MCDB131) without serum, or
with conditioned media harvested from unstimulated HUVECs.
Based on the experiments shown in Fig. 1A where we observed that
the filaments grew in size with time, we chose to incubate all samples for
35 h. Chemokines typically bind to GAGs via positively charged amino
acids, therefore, we added the GAG heparin in different concentrations
to some of the wells. In the first series, we added increasing
concentrations of heparin to cell growth medium without serum,
observing at low and medium concentrations of heparin (0.9 and
1.7 mg/ml, respectively) no evidence of filament formation of
RANTES (Fig. 3, left panel). However, following incubation with the
highest concentration of heparin (3.4 mg/ml), RANTES organized in a
structured pattern that nevertheless differed from that observed for
RANTES in HUVEC cultures (Fig. 3, left panel, lower image). In
the next series we added increasing concentrations of heparin to
conditioned media, observing even in the absence of heparin that
RANTES was distributed in an organized and distinct pattern (Fig. 3,
right panel, upper image). When increasing the concentration of
heparin (1.7 mg/ml) we observed that RANTES was organized in a
pattern reminiscent of the RANTES filaments in HUVECs, and when
reaching the highest level (3.4 mg/ml), RANTES was found in puncta
(Fig. 3, right panel, lower image). Taken together, these experiments
suggest that RANTES cannot alone organize into filaments and instead
depends on helper or scaffold molecules. In addition, RANTES can
organize into different patterns, likely depending on the type of
molecules that are present.
Heparan sulfate is involved in cell surface immobilization of
RANTES. It is well established that GAGs can immobilize chemo-
kines on cell surfaces5,9,26,27. Because of this knowledge, and the finding
that incubation of RANTES with heparin leads to formation of
organized structures of RANTES (Fig. 3, left panel), we wanted to
Figure 2 | Filaments of RANTES form independently of TNFa and IFNc-
stimulation. (A) HUVECs were stimulated with 1 ng/ml IL-1b, or 10 ng/
ml TNFa in combination with 1 ng/ml IFNc for 24 h and immunostained
with an antibody towards MCP-1. The insert shows immunostaining of
RANTES from the same experiment, in HUVECs stimulated with 10 ng/
ml TNFa1 1 ng/ml IFNc. (B) Left image; HUVECs were incubated with
1 mg/ml recombinant RANTES before fixation and immunostaining.
Right image; HUVECs were not stimulated but electroporated with a DNA
plasmid encoding RANTES before fixation and immunostaining of
RANTES with a rabbit anti-RANTES antibody. Labelling with ulex (green)
was included to visualize individual cells. Scale bars, 10 mm. All images
were acquired by confocal microscopy.
Figure 3 | RANTES is dependent on other molecules to form organized
structures. RANTES (1 mg/ml) was incubated either in cell growth
medium without serum or in conditioned cell growth medium containing
serum. The conditioned medium was harvested from unstimulated
cultures of HUVECs. Heparin was added and its final concentration is
indicated in each image. After 35 h, the samples were fixed and
immunostained with a rabbit antibody toward RANTES. The images were
acquired by widefield microscopy. Inserts show high magnification of
squared areas. Scale bars, 10 mm.
www.nature.com/scientificreports
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examine whether GAGs in HUVEC cultures affect the generation of
filaments. Monolayers of HUVECs were stimulated with TNFa 1
IFNc before treatment with a mixture of heparinase I, II, and III,
and immunostaining for RANTES. Compared to the control sample
(Fig. 4A, left image), heparinase treatment reduced the intensity of the
RANTES signal by 55% (Fig. 4A, right image), suggesting that heparan
sulfate is involved in surface binding. Aiming to verify this finding by
use of another approach, we stained TNFa 1 IFNc-stimulated
HUVECs with an antibody recognizing the epitope 10E4, a
common epitope in heparan sulfate28–30. Immunostaining revealed
different patterns of heparan sulfate distribution (Fig. 4B). One
pattern was cell-associated, showing elongated structures similar to
and overlapping with those of RANTES (Fig. 4B, upper panel), but
overt co-localization was not observed. Another pattern appeared to
be present at the cell border or between cells. At these sites, the
antibody labeled long thread-like structures, and filaments of
RANTES was observed along these structures (Fig. 4B, middle
panel, and Fig. S2). Finally, because incubation of RANTES in
conditioned media indicated that large scaffold molecules could
organize RANTES (Fig. 3, right panel; upper image), we also labeled
HUVEC cultures with biotinylated hyaluronan binding protein (bio-
HABP). HAPB shows high affinity for a decasaccharide unit of
hyaluronan, which can form large polymers up to 20,000 kDa that
organize into a wide variety of molecular architectures including fibrils
and cable-like structures31. Except from some regions with large
clusters of RANTES and HABP associated with HUVECs, we
observed no co-localization between RANTES and HABP (Fig. 4B,
lower panel). Between cells, HABP was found in large, round
structures that were somewhat irregular and negative for RANTES
(data not shown). Based on these experiments, we concluded that
heparan sulfate molecules bind RANTES in HUVEC cultures, but
the importance of other molecules for immobilization of RANTES
cannot be excluded.
Filamentous distribution of RANTES depends on the ability to
form higher-order oligomers. RANTES can self-associate and form
higher-order oligomers in a concentration-dependent manner5,32. In
contrast, two mutants of RANTES, E26A and E66A/E66S, show
strongly reduced ability of such oligomer formation, and are
instead restricted to form tetramers (E26A) and dimers (E66A/
E66S)16,32,33. Furthermore, the 40s loop (44RKNR47) is suggested to
be important for oligomerization as R44 may exert stabilization
forces to the dimer interface, and R47 is shown to interact with the
neighbouring molecule in RANTES structures16,34.
To elucidate whether the filamentous pattern of RANTES might
be related to the properties of oligomer formation we electroporated
HUVECs with DNA plasmids encoding E26A, 44AANA47, or E66A.
We also examined the mutant Y3A which shows in vivo properties
similar to 44AANA47 but has unknown oligomerization status34.
Microscopy after electroporation and immunostaining of the
mutants E26A, 44AANA47, and E66A revealed a pattern substantially
different from that of wild type (wt) RANTES (Fig. 5A). Themutants
mainly appeared in small granular structures as well as in the Golgi.
44AANA47 and E66A were also apparent throughout the cytoplasm,
reminiscent of endoplasmic reticulum staining (Fig. 5A). Only 10–
17% of the mutant-expressing HUVECs showed filamentous
RANTES compared to 98% for the wt (Fig. 5C). The mutant Y3A
distributed in a pattern similar to that of the other mutants suggest-
ing that it had lost the ability to form higher-order oligomers
(Fig. 5A).
To exclude that the dramatic reduction of filament formation was
caused by low RANTES expression, we performed several control
experiments. First, we compared the intensity of the signals for the
immunolabeled mutants towards that of the wt by recording images
at identical exposure times. By this comparison, we observed that the
signal intensity of filament-forming wtRANTES varied and that it
was present both at lower and higher levels than the signal of the
mutants on a per cell basis. Even cells expressing wtRANTES at low
levels (based on a very weak signal) showed a filamentous RANTES
pattern (data not shown). Moreover, we electroporated HUVECs
with low amounts of plasmid DNA encoding wtRANTES (4 mg
compared to 20 mg in the standard protocol) which resulted in a
dramatic reduction in protein expression and fewer positive cells.
Despite the low level, wtRANTES organized in filaments (data not
shown). Finally, we performed ELISA on supernatants harvested
fromHUVECs electroporated with plasmid DNA encoding the vari-
ous constructs. Both Y3A and E66A were present in higher amounts
than wt, whereas E26A and 44AANA47 were found in approximately
Figure 4 | RANTES is immobilized to the cell surface via heparan sulfate.
(A) HUVECs were stimulated for 48 h with 10 ng/ml TNFa 1 1 ng/ml
IFNc before half of the samples were incubated with a mixture of
heparinase I, II, and III (0.5 U/ml) for 2 h. Next, the cells were fixed and
immunolabelled with clone ID2/A12 and analyzed by widefield
microscopy. Scale bars, 50 mm. (B) HUVECs stimulated with 10 ng/ml
TNFa and 1 ng/ml IFNc were immunostained with antibodies towards
RANTES (rabbit anti-RANTES antibody) and the heparan sulfate epitope
10E4. Alternatively, biotinylated hyaluronan binding protein (HABP) was
used to label hyaluronan. The antibody towards 10E4 labelled elongated
structures in HUVECs (upper panel) and long structures at cell borders or
between cells (middle panel).Middle panel is a highmagnification from an
original 100 3 picture. Biotinylated HABP labelled irregular clusters in
HUVECs, and large, round structures between cells (lower panel). The
samples were analyzed following sequential scanning confocalmicroscopy.
Corner insets show high magnification of framed areas. Scale bars, 10 mm.
www.nature.com/scientificreports
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two-thirds and half the amount, respectively, of that measured for wt
(Fig. 5D). Altogether, these data confirmed that the different patterns
were not a result of various expression levels per cell or by the culture.
Therefore, our findings clearly suggest that organization into fila-
ments depends on the ability to form higher-order oligomers.
Next, to examine whether the mutant constructs of RANTES were
present on the endothelial cell surface or restricted to intracellular
compartments, we immunolabelled live HUVECs kept on ice and
compared the pattern towards that of fixed and permeabilized cells.
As shown in Fig. 5B (upper panel), the mutants Y3A and E26A
distributed in a granular pattern throughout the HUVEC surface
similar to that observed in permeabilized cells, suggesting that their
binding to the surface was not disrupted. We also calculated the ratio
between the number of cells expressing themutant on the surface and
the number of cells expressing the mutant after permeabilization
(Fig. 5E). By this analysis we found that the ability of surface express-
ion was not significantly affected for E26A or Y3A in comparison to
thewt. In contrast, we found dramatically reduced surface expression
for 44AANA47 and E66A.
RANTES does not co-localize with ICAM-1. Pre-existing
tetraspanin-enriched microdomains (TEMs) containing adhesion
receptors such as ICAM-1, VCAM-1, and CD44 are suggested to
function as adhesive platforms on the endothelial cell surface35,36.
Figure 5 | Oligomerization-deficient mutants of RANTES show distinct morphology and localization compared to the wild type (wt). (A) HUVECs
were electroporated with DNA plasmids encoding wtRANTES or oligomerization-deficient mutants and cultivated for 24 h before fixation. The cells
were permeabilized to label RANTES present intracellularly and on the surface with rabbit anti-RANTES antibody. Images were acquired by confocal
microscopy. Corner inset shows a cell electroporated with wtRANTES-encoding plasmid. Scale bars, 10 mm. (B) The experiment was performed as
indicated in A, but labelling was performed on live HUVECs kept on ice to detect cell surface-associated RANTES with rabbit anti-RANTES antibody.
Labelling with the lectin ulex was used to visualize individual cells. Images were acquired by sequential scanning confocal microscopy. Corner insets show
high magnification of framed areas or high magnification of a cell electroporated with DNA encoding wtRANTES. Scale bars, 10 mm (wt, scale bar 5
5 mm). (C) HUVECs were treated as described in A, and the number of RANTES-positive and filament-forming cells were counted. The graph presents
mean values of percentage of filament-forming cells related to the total number of RANTES-positive cells. 55–80 cells were evaluated for each construct in
one experiment (n5 3 experiments). Error bars indicate SEM. Themutants generated a significantly lower percentage of filament-forming cells than the
wt, p, 0.0001. (D) HUVECs electroporated with DNA encoding the indicated constructs were incubated for 30 h before supernatants were harvested.
The amount of RANTES in supernatants was quantified by ELISA utilizing recombinant RANTES as standard. Themutants were present in amounts that
differed significantly from the wt, p, 0.0001. Error bars indicate SEM, n5 3–6 experiments. (E) HUVECs were treated as indicated in A, but half of the
samples were kept live on ice during labelling to indicate cell surface-associated RANTES. Labelling with ulex was used to visualize individual cells. The
graph shows mean values of the percentage of filament forming-cells related to the total number of RANTES-positive cells. 55–80 cells were evaluated for
each construct in one experiment (n5 3 experiments). Error bars indicate SEM. Surface presentation of 44AANA47 and E66A differed significantly from
that of the wt, p , 0.0001. n.s., not significant.
www.nature.com/scientificreports
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Wewanted to examine whether RANTES localized in such platforms,
using ICAM-1 as a marker. Consistent with previous findings37,
activation of HUVECs with TNFa or TNFa combined with IFNc
upregulated the ICAM-1 expression in all cells. Interestingly, the
brightest cells had a speckled surface expression of ICAM-1
reminiscent of the pattern seen for RANTES. However, paired
immunostaining for RANTES and ICAM-1 showed spots of
overlapping signal but generally no co-localization (Fig. 6A).
Previous studies have demonstrated an impressive redistribution of
ICAM-1 during para- or transcellular leukocyte migration across the
endothelium. ICAM-1 was enriched in vertical microvilli-like
projections that embraced the leukocyte and drove redistribution of
their integrins into linear tracks parallel to the direction of
diapedesis35,38,39. To elucidate whether RANTES distributed together
with ICAM-1 into such a docking structure or transmigratory cup
upon leukocyte addition, we reproduced the experiments by
transfecting HUVECs to express RANTES, exposing them to
TNFa, and adding peripheral blood mononuclear cells to such
monolayers 20 min before fixation. While ICAM-1 was indeed
observed in projections surrounding the leukocyte, the same
projections were negative for RANTES (Fig. 6B). However,
RANTES could be observed close to ICAM-1. RANTES was also
observed at sites of docking or transmigration, but the strongest
signal was typically observed in areas which were weak or negative
for ICAM-1 (Fig. 6B, lower panel). Taken together, these experi-
ments suggest that RANTES is not present on ICAM-1 positive
microvillous-like projections. In addition, because RANTES did not
show a regular presence close to ICAM-1 on the surface, we suggest
that RANTES is not a crucial molecule of the endothelial adhesive
platform.
The RANTES filaments prevail flow forces. Because of the blood
flow, molecules on the endothelial cell surface or at sites of vascular
injury may be exposed to shear stress. To examine whether RANTES
filaments can persist or will be disrupted by shear forces, we
electroporated HUVECs with DNA encoding RANTES, cultivated
the cells on cover slips before exposing them to TNFa 1 IFNc and
mounting them in a laminar flow chamber. We chose to expose the
HUVECs to flow mimicking shear stress of 1 dyne/cm2 as the force
has been shown to support adhesion of both monocytes and
lymphocytes40,41. Four minutes after exposure to flow, the
RANTES filaments were still present, suggesting that they can
exist in vivo (Fig. 7A). In other experiments, peripheral blood
mononuclear cells visualized by anti-CD45 staining were added
under flow conditions. Although RANTES filaments and
RANTES-positive platelets could be observed in close proximity to
Figure 6 | RANTES shows distinct localization from that of ICAM-1.
(A) Localization of RANTES compared to that of ICAM-1 after
electroporation of HUVECs with plasmid DNA encoding wtRANTES and
stimulation with TNFa before fixation, permeabilization and
immunolabelling. Corner insets show high magnification of framed areas.
Scale bar, 10 mm. (B) HUVECs were treated as indicated in (A) before
incubation with MCP-1, followed by addition of peripheral blood
mononuclear cells for 20 min followed by fixation, permeabilization, and
immunolabelling. Corner insets show high magnification of framed areas,
which are areas where one leukocyte has transmigrated. Arrows in the
lower panel indicate two leukocytes that may have transmigrated. Original
magnification in all panels, 3 100. Scale bars, 10 mm. A rabbit anti-
RANTES antibody was utilized in immunolabelling of RANTES. All
samples were analyzed by use of sequential scanning confocal microscopy.
Figure 7 | RANTES filaments are present after exposure to shear stress.
(A) HUVECs were electroporated with DNA encoding RANTES,
cultivated on cover slips before stimulation with TNFa 1 IFNc for 30 h.
RANTES was labeled with an anti-RANTES antibody (clone 21418), and
the cover slips were mounted in a laminar flow chamber. The flow rate was
adjusted to mimic vessel wall shear stress of 1 dyne/cm2. The images were
acquired by confocal microscopy before (left image, 0 min) and after
4 min with exposure to flow forces (right image, 4 min). (B) HUVECs
were treated as described in (A) except that they were not labeled with anti-
RANTES antibody before exposure to flow. Human peripheral blood
mononuclear cells were labeled with an anti-CD45 antibody, resuspended
in medium and applied by a pump to the flow chamber (1 dyne/cm2).
After 10 min, the cells were labeled with a rabbit anti-RANTES antibody.
Images were acquired by sequential scanning confocal microscopy. Arrows
and arrow heads indicate RANTES filaments and RANTES positive
platelets, respectively. Original magnification in all panels, 3 100. Scale
bars, 10 mm.
www.nature.com/scientificreports
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adhering mononuclear leukocytes, we could not observe RANTES-
positive structures resembling a transmigratory cup (Fig. 7B). Taken
together, the RANTES filaments with or without exposure to flow
forces appeared to be similar, suggesting that they can be present in
vivo.
Discussion
Several lines of evidence support a role for higher-order, oligomerized
chemokines in leukocyte recruitment. First, wtRANTES but not dis-
aggregated mutants, recruits leukocytes to the peritoneal cavity13,14.
Second, disaggregated mutants of RANTES fail to support leukocyte
arrest to cultured endothelial cells under flow conditions42, and some
of these mutants are powerful anti-inflammatory agents14,34,43. Taken
together, these findings point to a possible role for oligomerized
RANTES at the endothelial cell surface. Here we show for the first
time morphological evidence that RANTES indeed binds to the
endothelial cell surface in a regular, filamentous pattern. This
depends on the oligomerization state of RANTES as all disaggregated
mutants (identical or complementary to those tested under flow or in
vivo) failed to appear as filaments on cultured endothelial cells.
Our observation that themutant 44AANA47 did not form filaments
(likely because it failed to bind the endothelial cell surface) fits well
with its rapid appearance in peripheral blood after intraperitoneal
injection14, indicating that the mutant is not trapped in the tissue/
extracellular matrix as efficiently as the wt and/or does not bind to
the endothelial cell surface after abluminal to luminal transcytosis.
This hypothesis would also be compatible with the independent
observation that recombinant 44AANA47-RANTES added to cultures
of human microvascular endothelial cells does not bind to the cell
surface42. Taken together with the observation that the number of
filaments was reduced after heparinase treatment, these data are
consistent with the view that 44RKNR47 constitutes the principal
GAG-binding site44, and that binding to GAG is crucial for immob-
ilization to the endothelial cell surface5,8,13.
In our experiments, filament formation generated by the tetramer-
restricted mutant E26A was reduced by more than 90% compared to
the wt. Following injection into the mouse peritonitis model, E26A
and wtRANTES appeared to be equally efficient in recruitment of
cells, and it was concluded that the smallest leukocyte-recruiting
form of RANTES is a tetramer13. This conclusion was based upon
counts of the total number of cells in peritoneal lavage harvested
18 hours after injection of wt and E26A protein13. However, when
considering different steps of the leukocyte extravasation cascade in
vitro under flow conditions, the E26A mutant showed reduced
potency compared to the wtRANTES. The mutation E26A reduced
the number of monocytes that arrested to the endothelial monolayer,
and the authors suggested that RANTES oligomers are required to
bridge surface-bound RANTES and CCR142. Thus, in addition to the
inability to form filaments, the E26Amutant shows reduced potency
compared to that of wtRANTES in ‘‘isolated’’ steps of the extravasa-
tion of leukocytes.
The mutant Y3A shares with the heparin-deficient mutant
44AANA47 the inability to recruit leukocytes in inflammation and
the ability to inhibit cell recruitment induced by wtRANTES34. In
contrast to the 44AANA47 variant, Y3A binds heparin. We found that
Y3A, similar to E26A, appeared in a granular pattern on the endothe-
lial cell surface, indicating that its ability to form oligomers is abol-
ished. Finally, the E66A mutant which forms dimers, was detected
intracellularly and was secreted in similar amounts to that of Y3A.
Recombinant E66A was reported to bind to the surface of human
microvascular endothelial cells42 whereas this was not the case in our
study. Binding of RANTES molecules to heparan sulfate have been
suggested to occur by positive cooperation, meaning that the binding
affinity for the second RANTES molecule is higher than for the first
one45. Given that the model of positive cooperation applies for bind-
ing of RANTES units larger than dimers, the affinity for E66A could
be lower than for the other constructs and may explain its reduced
surface presentation.
Interestingly, Wang et al. proposed a model for how RANTES
organizes into oligomers based on detailed structural analyses16:
The RANTES dimer is the building block, and long linear polymeric
chains can form by contacts between residues of the second b-strand
and residues at the C-terminal helix from one monomer of a dimer
and similar residues in the neighbouring dimer. Consistent with the
reduced ability of E26A and E66A to oligomerize and form filaments,
both E26 and E66 appear to exert stabilization forces on the inter-
action between RANTES dimers. Wang et al. observed long oligo-
mers at pH 7, and suggested that binding to sulfated GAGs would
further promote length, as negatively charged GAG can neutralize
electric repulsion forces between RANTES dimers16. In our cell cul-
tures, presence of RANTES filaments was at least partially dependent
on heparan sulfate as there were fewer filaments following hepari-
nase treatment. A crucial role for GAGs in promoting filament
length, was supported by the finding that in the absence of cells,
heparin was needed for filaments to appear.
During the initial events of leukocyte extravasation, membrane
projections would probably increase the accessibility of the endothe-
lium towards that of the leukocyte. Luminal endothelial membrane
projections have been given names such as microfolds, microvilli,
filopodia, protrusions, and nanotubes8,22–24, and some of these are
likely different structures with distinct functions. Similar to what was
recently reported24, we observed long membrane projections lateral
to the endothelial cell surface as well as shorter membrane projec-
tions. Interestingly, Whittall et al. found that leukocytes interacted
with both the long and short projections24. By immunogold labeling
of RANTES and electron microscopy, we observed a tendency of
more labeling on the membrane projections than on the remaining
plasma membrane. Unfortunately, the lower staining intensity
obtained by immunogold labeling than by immunofluorescence,
combined with the lost orientation of cells after scraping, did not
allow us to draw firm conclusions on where the RANTES filaments
localized at an ultrastructural level. Nevertheless, chemokines loca-
lized to membrane projections have been reported by others. For
example, IL-8 immunoreactivity was detected at tenfold higher levels
on vascular luminal projections than on the remaining plasmamem-
brane8. RANTES was also detected on such membrane projections8.
Upon binding to leukocyte chemokine receptors, chemokines can
trigger complex signaling transduction cascades leading to activation
of integrins and, ultimately, to adhesion via binding to adhesion
molecules such as ICAM-146. As this occurs rapidly and integrin
activation is a reversible process, co-localization of RANTES and
ICAM-1 could increase the possibility for the activated leukocyte
to interact with ICAM-1. However, we were unable to observe overt
co-localization both during the process of peripheral blood mono-
nuclear cell extravasation and in the absence of leukocytes. By scan-
ning electron microscopy we observed membrane projections
resembling microfolds or small villi on the HUVEC surface
(Øynebra˚ten et al., unpublished data). This pattern was reminiscent
of the ICAM-1 distribution observed after immunofluorescence, and
our immunofluorescent data are very similar to what has been
reported by others with ICAM-1 being present on microvilli or
microvilli-like projections38,39,47,48. Taken together, our data suggest
that RANTES and ICAM-1 are present at different membrane sites.
We have stained for numerous chemokines after cytokine-stimu-
lation or transfection of chemokine-encoding DNA into cultures of
endothelial cells20,21 (Øynebra˚ten et al., unpublished data). In our
studies the filaments were unique to RANTES, and due to high
positive charge, it is proposed that RANTES is hindered from form-
ing the more common organization of chemokine high order oligo-
mers, i.e. globular complexes7,16. However, it cannot be excluded that
other chemokines than those we tested, for example MIP-1a/CCL3
and MIP-1b/CCL4, can form such elongated structures, although
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their charge and their binding to GAGs differ from that of
RANTES16,49. RANTES organized in different structures depending
on the conditions in the well (presence of cells, heparin, conditioned
media). Therefore, our data suggest that RANTES bindingmolecules
are crucial for the organization of RANTES and its presentation to
chemokine receptors. Given that filaments are formed in vivo, our
data imply that presence of filaments may vary between types of
endothelial cells, the tissue site, and inflammatory status.
In conclusion, our data together with biochemical analyses16
strongly suggest that RANTES filaments can form and be present
at physiological conditions in vivo. Moreover, that filaments of
RANTES can be of functional importance is supported by a study
that shows reduced ability of the RANTES tetramer E26A to arrest
monocytes on endothelial monolayers42. What might be the advant-
age of presenting RANTES in long filaments on the vascular surface?
Clearly, the inherent ability to focus low numbers of molecules for
presentation in a patch of concentrated chemokine to rolling leuko-
cytes appears intuitively pleasing. Another, closely related function
of RANTES filaments could be to increase the accessibility of the
ligand towards the receptor. In fact, Proudfoot et al. suggested that
oligomerization of chemokines might be important for those whose
GAG binding sites overlap with the receptor binding sites, as is the
case for RANTES, MCP-1 and MIP-1b so that while some chemo-
kine subunits bind to GAGs others can be exposed to the receptor13.
The ability to organize into various forms from monomers to long
filaments may also generate functionally distinct ligands7,42,50–52.
Moreover, it is well documented that chemokines exert effects
through dimers or oligomers of G-protein coupled receptors.
Although the general view is that the receptor dimerizes shortly after
synthesis in the endoplasmic reticulum53,54, a possible function of the
RANTES filaments could be to facilitate ligand binding of two or
more receptors. This could increase the number of integrins that are
activated and the time for which a leukocyte presents activated integ-
rins, and thereby promote the probability of leukocyte interaction
with adhesion molecules and subsequent arrest to the endothelium.
Methods
Antibodies and reagents. Fetal bovine serum (FBS), gentamicin, fungizone, L-
glutamine, MCDB 131, and Opti-MEM I were purchased from Life Technologies
(Paisley, UK), and trypsin-EDTA was from Bio-Whittaker (Walkersville, MD).
Recombinant human TNFa and IFNc, recombinant human epidermal growth factor
(EGF), recombinant human basic fibroblast growth factor (bFGF), recombinant
human MCP-1, mouse and goat anti-human RANTES antibodies (MAB678, clone
21418, and BAF278, respectively) were purchased from R&D Systems (Abingdon,
UK). A second mouse anti-human RANTES antibody was a kind gift from M.
Sticherling (Klinikum der Christian-Albrechts-Universita¨t zu Kiel, Germany), and
mouse anti-human RANTES clone VL1 was from Biosource (Camarillo, CA). Rabbit
anti-human RANTES (500-P36) was from Peprotech (Rocky Hill, NJ), and mouse
anti-heparan sulfate, clone 10E4, and hyaluronan binding protein was from
Seikagaku Corporation (Tokyo, Japan). The secondary rabbit anti-goat antibody used
for electron microscopy was from DAKO (Glostrup, Denmark). The fluorescent
(alexa 488 or 594) secondary anti-mouse or anti-rabbit antibodies were from
Molecular Probes (PoortGebouw, The Netherlands), fluorescein ulex europaeus
agglutinin I, and biotinylated horse anti-mouse IgG from Vector Laboratories
(Burlinghame, CA), streptavidin-Cy2 from Amersham Pharmacia Biotech
(Piscataway, NJ), and streptavidin-Cy3 from Jackson (West Grove, PA). Protein A
coupled to gold particles of different sizes was purchased from George Posthuma
(Utrecht, The Netherlands). Heparin was from LeoPharma (Ballerup, Denmark). All
other reagents were from Sigma Chemical (St Louis, MO).
Constructs.RANTESwas amplified from cDNAderived fromTNFa/IFNc-activated
HUVECs. Primers (forward 5’-CTCTCCCAAGCTTACCATGAAGGTCT-3’ and
reverse 5’- AGAATCTAGACTAGCTCATCTCCAAAGAGTTGATGTACT-3’)
were designed to introduce HindIII and XbaI restriction sites (underlined),
respectively, that were used to clone the RANTES-encoding DNA fragment into the
pcDNA3.1(1) vector (Invitrogen, Carlsbad, CA). Based on this construct, alanine
exchange of selected amino acids was performed using the QuikChangeTM Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, CA) according to the instructions by
the manufacturer. The following primers were used to introduce the mutations,
giving the sequence of the sense primers with mutated nucleotides written with small
letters: Y3A: 5’-CTGCATCTGCCTCCCCAgcTTCCTCGGACACCACACC-3’;
E26A: 5’-CCCGTGCCCACATCAAGGcGTATTTCTACACCAGTGGCAAGTG -
3’; 44AANA47: 5’GCAGTCGTCTTTGTCACCgcggcGAACgcCCAAGTGTG-
TGCCAACC -3’; E66A: 5’- CGGGAGTACATCAACTCTTTGgcGATGAGCGC-
GGTACCG -3’. The corresponding antisense primers were complement reverse.
Cells. Umbilical cords were obtained from the Department of Gyneacology and
Obstetrics, Oslo University Hospital - Rikshospitalet, with the mothers’ written
permission, and in accordance with an approved study protocol (Regional
Committee for Medical Research Ethics, Health Region South, Norway, Approval S-
05152). Human umbilical vein endothelial cells (HUVECs) were isolated as described
by Jaffe55 and cultured in MCDB 131 containing 7.5% FBS, 10 ng/ml recombinant
human EGF, 1 ng/ml recombinant human bFGF, 1 mg/ml hydrocortisone, 50 mg/ml
gentamicin, and 250 ng/ml fungizone. The cells were maintained at 37uC in humid
95% air/5% CO2 atmosphere and split at ratio 1/3. The cultures were used at passage
level one to six.
Electroporation.HUVECswere trypsinized, washed and resuspended inOptiMEM I
containing 2.5% FBS, before transfection by electroporation using 20 mg DNA
according to the protocol 0394 from BTX (Holliston, MA). Following
electroporation, the cells were cultivated for approximately 24 h before fixation or
staining of cell surface associated RANTES.
Digestion of heparan sulfate. To examine whether RANTES was bound to the
surface in a GAG dependent manner, monolayers of HUVECs were stimulated with
10 ng/ml TNFa combined with 1 ng/ml IFNc for 48 h before incubation with a
mixture of heparinase I, II, and III (0.5 U/ml) for 2 h at 30uC and subsequently fixed
and labelled for RANTES as described above.
Sterile testicular hyaluronidase (1.0 mg/ml stock in DMEM; type IV; Sigma) or
Streptomyces hyaluronidase [100 turbidity reducing units (TRU)/ml stock in DMEM;
Seikagaku] was added directly to cell cultures to yield a final concentration of 20, 50,
or 100 mg/ml and 20 TRU/ml, respectively, and incubation continued for 3 hr at
37uC in a CO2-containing atmosphere.
Adhesion of peripheral blood mononuclear cells. HUVECs were electroporated
with wtRANTES and cultivated on gelatine-coated chamberslides (Lab-Tek) for
approximately 24 h before addition of 100 ng/ml TNFa (final concentration). After
12 h of stimulation, the cells were cultivated with 200 ng/ml recombinant human
MCP-1 for 20 min. The cultures were then washed and peripheral blood
mononuclear cells were added to the HUVECs 20 min before fixation. Mononuclear
cells were isolated by centrifugation on Lymphoprep according to instructions of the
manufacturer (Nycomed, Oslo, Norway).
Immunostaining protocols and fluorescencemicroscopy.HUVECswere cultivated
on gelatine (1% (w/v)) coated 103 10 mmglass coverslips or Lab-Tek chamber slides
(Nunc, Roskilde, Denmark). For labelling of permeabilized HUVECs, cells were fixed
in 4% paraformaldehyde for 10–15 min before washing in phosphate-buffered saline
(PBS). For immunostaining, the fixed monolayers were permeabilized with 0.05%
saponin before incubation with the antibodies, alternatively, 0.1% saponin was
included in all solutions. In another set of experiments, recombinant RANTES was
added to gelatine (1% (w/v)) coated chamber slides in the absence of HUVECs for
35 h. RANTES was incubated in endothelial cell growth mediumMCDB 131 without
FBS or in conditioned MCDB 131 with FBS. Alternatively, heparin (LeoPharma,
Ballerup, Denmark) was added in different concentrations before fixation. After
sequentially labelling with primary antibodies and secondary reagents, the slides were
mounted in mowiol combined with DABCO or polyvinyl alcohol. Labelling of cell
surface-associated RANTESwas performed on ice with cold (4 uC) antibody solution.
The primary biotinylated antibody was added for 45 min before fixation in
paraformaldehyde followed by washing in PBS and sequential labelling with
streptavidin-Cy3 or anti-rabbit Cy2. The immunostained cells were examined by an
Axioplan 2 imaging Zeiss microscope using Plan-NEOFLUAR 403 and 1003 oil-
objectives or a confocal laser scanningmicroscope (Leica TCS, Heidelberg, Germany)
with A Plan apochromat 1003/1.4 oil objective equipped with an Ar (488 nm) and a
He/Ne (543 and 633 nm) laser. Cells that expressed two or more RANTES filaments,
were defined as filament-forming cells in the experiments shown in Fig. 5.
Cryo-electron microscopy and immunogold labelling. HUVECs were grown in
10 cm diameter culture dishes and cytokine-stimulated for 36 h before fixation in
0.1 M PBS containing 4% paraformaldehyde alone or a combination of 0.1%
glutaraldehyde and 4% paraformaldehyde for 3 h at room temperature. After
washing in 13 PBS, cells were scraped-off and spun down. Cell pellets were
embedded in 1 3 PBS/12% gelatine and after infiltration with 2.3 M sucrose over-
night at 4uC, cut into small blocks, mounted on pins and frozen in liquid nitrogen.
Ultrathin cryosections of about 60–70 nm thickness were obtained by cutting at
2120uC with a Reichert Ultracut S ultracryomicrotome from Leica (Heidelberg,
Germany). Cryosections were picked up in a 151 mixture of 2% methylcellulose and
2.3 M sucrose. Cryosections were then sequentially incubated with the goat anti-
human RANTES antibody, the rabbit anti-goat antibody, and protein A-gold
particles diluted in 13 PBS/1% BSA for 30 min at room temperature with extensive
washing between the incubations. (In an alternative immunolabeling protocol, clone
ID2/A12was utilized.) Finally, cryosections were contrasted with a 159mixture of 3%
uranyl-acetate and 2% methylcellulose before examination. When quantifying the
distribution of RANTES, 30 pictures were utilized and gold particles associated with
membrane projections versus the remaining plasma membrane were counted.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 9261 | DOI: 10.1038/srep09261 8
RANTES filaments at flow conditions. Glass coverslips were coated with gelatine
(1% (w/v)), HUVECs were added and cultivated at standard conditions for 24 h
before stimulation for approximately 40 h with TNFa (10 ng/ml) and IFNc (1 ng/
ml). Next, the cover slips were mounted in a flow chamber which was placed on a
microscope stage for live imaging. The stage was enclosed by an incubator with
temperature 37 uC and CO2 adjusted to 6%. By use of a pump, medium with
temperature 37uC was applied to the flow chamber corresponding to shear stress
1 dyne/cm2. The flow rate was calculated by use of the formula T5 3mQ/2ba2, where
T 5 wall shear stress, m 5 coefficient of viscosity (0.7 centipoise), Q 5 volumetric
flow rate (cm3/s), a 5 half channel height (127 3 1024 cm), and b 5 channel width
(0.8 cm)56. Confocal images were acquired using anOlympus FluoView1000 inverted
microscope with a PlanApo3 60/1.42 oil objective (Olympus, Hamburg, Germany).
ImageJ (NIH, Bethesda, MD, USA) and Adobe Photoshop (Adobe systems, San Jose,
CA, USA) were used to process and prepare the images.
Statistical analyses. Statistical analyses were performed by use of GraphPad Prism
version 6.04. Responses for each experimental group are presented as means with
SEM. Differences between groups were analyzed by using one-way ANOVA with the
Sˇida´k method for multiple comparisons. p-values, 0.05 were considered significant.
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